Cambrex Corp. (CBM) Misses Q4 EPS by 2c, Offers Weak FY12 Sales Guidance
Tweet
Share
E-mailGet Alerts CBM Hot Sheet
Price: $59.99 --0%
Financial Fact:
Income from continuing operations: 0.43
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income from continuing operations: 0.43
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cambrex Corp. (NYSE: CBM) reported Q4 EPS of $0.10, $0.02 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $67.1 million versus the consensus estimate of $64.85 million.
Cambrex Corp. sees FY2012 EBITDA of $47-$53 million. Cambrex Corp. sees FY2012 revenue of growth of 2-6%, versus the consensus of 5%.
For earnings history and earnings-related data on Cambrex Corp. (CBM) click here.
Cambrex Corp. sees FY2012 EBITDA of $47-$53 million. Cambrex Corp. sees FY2012 revenue of growth of 2-6%, versus the consensus of 5%.
For earnings history and earnings-related data on Cambrex Corp. (CBM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- Forum Markets, Incorporated (FRMM) Tops Q2 EPS by 29c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
